1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. USA CONTINUOUS GLUCOSE MONITORING (CGM) MARKET, BY APPLICATION
5.1. Introduction
5.2. Diabetes Patients
5.3. Critical Patients
6. USA CONTINUOUS GLUCOSE MONITORING (CGM) MARKET, BY END-USER INDUSTRY
6.1. Introduction
6.2. Hospitals
6.3. Diagnostic Centers & Clinics
6.4. Home Care
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. Dexcom, Inc.
8.2. Abbott Laboratories
8.3. Medtronic plc
8.4. Senseonics Holdings, Inc.
8.5. Ascensia Diabetes Care
8.6. Insulet Corporation
8.7. Roche Diabetes Care, Inc.
8.8. Tandem Diabetes Care, Inc.
8.9. GlySens Incorporated
8.10. Echo Therapeutics, Inc.